Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 8-K Event Results of operations · Regulation FD disclosure
  2. 425 Deal Prospectus/Communication re Business Combination
  3. 425 Deal Prospectus/Communication re Business Combination
  4. 425 Deal Prospectus/Communication re Business Combination
  5. 425 Deal Prospectus/Communication re Business Combination
  6. 8-K Event Material agreement · Results of operations · Executive or director change · Other events
  7. 8-K Event Material agreement · Other events
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 4 Grant or award Director acquired 676 shares (grant or award)
  10. 4 Grant or award Director acquired 1,353 shares (grant or award)
  11. 4 Grant or award Director acquired 676 shares (grant or award)
  12. 4 Open-market sale Director sold 70,000 shares at $8.51 ($595,868)
  13. 144 Insider Sale of Securities
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 8-K Event Executive or director change
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations · Regulation FD disclosure
  18. 8-K Event Executive or director change · Regulation FD disclosure
  19. 4 Grant or award CFO & Head of Corp Development acquired 147,000 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 6 of 99 · 1,967 filings